Janus Henderson Group PLC Catalyst Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 751,562 shares of CPRX stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

751,562

Previous 319,829 134.99%

Holding current value

$15.4 Million

Previous $7.76 Million 110.29%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.4 - $26.31 $9.24 Million - $11.4 Million	431,733 Added 134.99%	751,562 $16.3 Million
Q1 2025 May 15, 2025	SELL	$19.53 - $25.74 $3.05 Million - $4.02 Million	-156,194 Reduced 32.81%	319,829 $7.76 Million
Q4 2024 Feb 14, 2025	BUY	$19.73 - $23.93 $2.29 Million - $2.77 Million	115,832 Added 32.16%	476,023 $9.93 Million
Q3 2024 Nov 14, 2024	SELL	$15.19 - $21.35 $27.6 Million - $38.8 Million	-1,815,450 Reduced 83.44%	360,191 $7.16 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $8.08 Million - $9.32 Million	-550,747 Reduced 20.2%	2,175,641 $33.7 Million
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $20.9 Million - $27.2 Million	1,587,794 Added 139.45%	2,726,388 $43.5 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $8.61 Million - $12.6 Million	730,695 Added 179.14%	1,138,594 $19.1 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $1.19 Million - $1.52 Million	101,392 Added 33.08%	407,899 $4.77 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $3.03 Million - $4.76 Million	263,116 Added 606.38%	306,507 $4.12 Million
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $335,197 - $492,043	23,375 Added 116.78%	43,391 $719,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $12 - $19	-1 Reduced -0.0%	20,016 $372,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $306,735 - $674,297	-43,447 Reduced 68.46%	20,017 $257,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $376,017 - $517,250	-60,356 Reduced 48.74%	63,464 $445,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $179,090 - $280,271	-33,727 Reduced 21.41%	123,820 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $74,289 - $106,229	14,259 Added 9.95%	157,547 $1.07 Million
Q3 2021 Nov 16, 2021	SELL	$4.85 - $6.04 $129,858 - $161,721	-26,775 Reduced 15.74%	143,288 $759,000
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $729,570 - $1.03 Million	170,063 New	170,063 $978,000

Others Institutions Holding CPRX

# of Institutions

386

Shares Held

103M

Call Options Held

Put Options Held

277K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.11B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Catalyst Pharmaceuticals, Inc. Transaction History